Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: Five year follow-up of a prospective controlled study

Bone ◽  
2011 ◽  
Vol 49 (5) ◽  
pp. 1005-1009 ◽  
Author(s):  
Valérie Gangji ◽  
Viviane De Maertelaer ◽  
Jean-Philippe Hauzeur
2017 ◽  
Vol 26 (6) ◽  
pp. 1059-1066 ◽  
Author(s):  
Ja Kyung Kim ◽  
Soo-Jeong Kim ◽  
Yuri Kim ◽  
Yong Eun Chung ◽  
Young Nyun Park ◽  
...  

2008 ◽  
Vol 8 (6) ◽  
pp. 705-712 ◽  
Author(s):  
Yoshihito Tachi ◽  
Daisuke Fukui ◽  
Yuko Wada ◽  
Megumi Koshikawa ◽  
Shigetaka Shimodaira ◽  
...  

2002 ◽  
Vol 73 (4) ◽  
pp. 1210-1215 ◽  
Author(s):  
Kimikazu Hamano ◽  
Tao-Sheng Li ◽  
Toshiro Kobayashi ◽  
Ken Hirata ◽  
Masafumi Yano ◽  
...  

2002 ◽  
Vol 11 (8) ◽  
pp. 747-752 ◽  
Author(s):  
Kensuke Esato ◽  
Kimikazu Hamano ◽  
Tao-Sheng Li ◽  
Akira Furutani ◽  
Atsushi Seyama ◽  
...  

Neovascularization has recently been used as a new treatment for severe ischemic disease. We tried to induce therapeutic neovascularization by autologous bone marrow cell implantation (BMCI) in eight selected patients with chronic peripheral arterial disease (PAD), in whom traditional treatments had failed. Improvement of subjective symptoms was seen in seven patients after treatment. Of three limbs with toe or finger ulceration, complete healing was achieved in two, while the other one became less severe after treatment. No relative toxicity was observed in any of the patients. BMCI might be a feasible treatment for selected patients with chronic PAD.


Sign in / Sign up

Export Citation Format

Share Document